Results 11 to 20 of about 1,634 (199)

Atosiban-induced acute pulmonary edema: A rare but severe complication of tocolysis

Heliyon, 2023
Background: Atosiban is commonly used to delay premature labor in pregnant women and is thought to have few side effects. Objectives: To report a case of acute pulmonary edema (APE) following administration of atosiban and conduct a systematic review to ...
Zuwei Yang, Wei Wu, Yi Yu, Haiyan Liu
doaj   +2 more sources

Efficacy of atosiban for repeated implantation failure in frozen embryo transfer cycles

Scientific Reports, 2023
Atosiban was commonly added to improve pregnancy outcomes of patients with repeated embryo implantation failure (RIF). In this study, we aimed to investigate the effect of atosiban before transferring the frozen-thawed embryo to RIF patients.
Xiufang Li, Yanbo Du, Xu Han, Huidan Wang, Yan Sheng, Fang Lian, Qingfeng Lian   +6 more
doaj   +2 more sources

Atosiban application in fresh ET cycle is effective for women undergoing repeated embryo implantation failures, especially for advanced-age obese patients

Scientific Reports, 2023
To assess the effect of atosiban in pregnancy outcomes of the fresh embryo transfer (ET), the retrospective cohort study was conducted. Six hundred and eighty-nine cases (using atosiban) and 1377 age and ET cycle-matched controls were collected from the ...
Jie Li, Sien Mo, Zhong Lin, Qiuling Shi
doaj   +2 more sources

A Comparative Study to Determine the Efficacy of Atosiban versus Nifedipine in Management of Preterm Labour [PDF]

Journal of Clinical and Diagnostic Research
Introduction: Preterm Labour (PTL) remains a significant challenge in obstetrics, contributing to neonatal morbidity and mortality. The management of PTL involves the use of tocolytic agents to delay delivery, thereby allowing for further foetal ...
Vidya Gaikwad, Jay Patel, Suhas Gaikwad
doaj   +2 more sources

Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis

BMC Pregnancy and Childbirth, 2022
Background Worldwide, nifedipine and atosiban are the two most commonly used tocolytic agents for the treatment of threatened preterm birth. The aim of this study was to evaluate the effectiveness of nifedipine and atosiban in an individual participant ...
Tijn M. S. van Winden, Tobias A. J. Nijman, C. Emily Kleinrouweler, Raed Salim, Maryam Kashanian, Wafa R. Al-Omari, Eva Pajkrt, Ben W. Mol, Martijn A. Oudijk, Carolien Roos   +9 more
doaj   +2 more sources

Arrest of mouse preterm labor until term delivery by combination therapy with atosiban and mundulone, a natural product with tocolytic efficacy

Pharmacological Research, 2023
There is a lack of FDA-approved tocolytics for the management of preterm labor (PL). In prior drug discovery efforts, we identified mundulone and mundulone acetate (MA) as inhibitors of in vitro intracellular Ca2+-regulated myometrial contractility.
Shajila Siricilla, Christopher J. Hansen, Jackson H. Rogers, Debasmita De, Carolyn L. Simpson, Alex G. Waterson, Gary A. Sulikowski, Stacey L. Crockett, Naoko Boatwright, Jeff Reese, Bibhash C. Paria, J. Newton, Jennifer L. Herington   +12 more
doaj   +3 more sources

A randomized double blind comparison of atosiban in patients with recurrent implantation failure undergoing IVF treatment

Reproductive Biology and Endocrinology, 2022
Background Patients with recurrent implantation failure (RIF) may have more uterine contractions. Several observational studies suggested that atosiban administration around embryo transfer resulted in higher pregnancy rates in RIF patients.
Chuan Ling Tang, Qi Yue Li, Feng Lian Chen, Chen Ting Cai, Yue Yan Dong, Yuan Yuan Wu, Jian Zhi Yang, Mei Zhao, Feng Li Chi, Ling Hong, Ai Ai, Miao Xin Chen, Kun Ming Li, Xiao Ming Teng, Zhi Qin Chen   +14 more
doaj   +2 more sources

Effect of atosiban on in vitro fertilization pregnancy outcome among women with endometriosis in presence or absence of adenomyosis

Taiwanese Journal of Obstetrics & Gynecology, 2023
Objective: This study aimed to assess the effect of atosiban on in vitro fertilization (IVF) pregnancy outcome among women with both endometriosis and adenomyosis, and compared it to that of patients with endometriosis but without adenomyosis and that of
Chih-Wei Lin, Meng-Hsing Wu, Yu-Lin Mau, Pei-Fang Su, Huang-Tz Ou   +4 more
doaj   +2 more sources

Effectiveness of atosiban in women with previous single implantation failure undergoing frozen-thawed blastocyst transfer: study protocol for a randomised controlled trial

BMJ Open, 2023
Background Uterine contractions may interfere with embryo implantation in assisted reproductive technology. To reduce these contractions and improve success rates, the oxytocin antagonist atosiban has been suggested for administration during embryo ...
Wentao Li, Ben W Mol, Shan Liu, Chen Yang, Juanzi Shi, He Cai, Jinlin Xie, Lijuan Chen   +7 more
doaj   +2 more sources

The effectiveness and safety of continuous and repeated treatment of atosiban in twin pregnancy with threatened preterm labor: A propensity score-matched study. [PDF]

PLoS ONE
PurposeThis retrospective cohort study aimed to evaluate the effects and adverse outcomes of continuous and repeated treatment with atosiban in twin pregnancies with threatened preterm labor.Patients and methodsThe study was conducted at the Department ...
Hao Zhu, Weirong Gu, Bian Wang, Rong Hu
doaj   +2 more sources